Qiang Cao Selected Research

Qiang Cao Research Topics

Disease

41	Neoplasms (Cancer) 01/2024 - 01/2006
16	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 01/2013
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2012
9	Inflammation (Inflammations) 11/2016 - 01/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 12/2017
6	Atherosclerosis 01/2017 - 04/2012
5	Non-Muscle Invasive Bladder Neoplasms 12/2023 - 01/2021
5	Insulin Resistance 11/2023 - 04/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 07/2011
4	Carcinogenesis 05/2023 - 09/2010
3	Obesity 11/2023 - 11/2016
3	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2020
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020 - 01/2019
3	Hyperlipidemias (Hyperlipidemia) 01/2017 - 03/2013
2	Carcinoma (Carcinomatosis) 03/2024 - 01/2010
2	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2022
2	Infections 01/2023 - 11/2012
2	Neoplasm Metastasis (Metastasis) 04/2018 - 03/2016
2	Hypertension (High Blood Pressure) 01/2017 - 02/2016
2	Body Weight (Weight, Body) 11/2015 - 12/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2014 - 01/2006
2	Stroke (Strokes) 09/2014 - 01/2006
1	Tertiary Lymphoid Structures 01/2024
1	Lymphatic Metastasis 12/2023
1	COVID-19 11/2023
1	Hypersensitivity (Allergy) 10/2023
1	Egg Hypersensitivity (Egg Allergy) 10/2023
1	Food Hypersensitivity (Food Allergy) 10/2023
1	Poisoning 10/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2023
1	Multiple Myeloma 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Pneumonia (Pneumonitis) 01/2023

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2005
5	Leucine (L-Leucine)FDA Link 01/2017 - 01/2015
5	LDL Receptors (LDL Receptor)IBA 01/2016 - 04/2012
5	LipidsIBA 01/2016 - 04/2012
5	CholesterolIBA 01/2016 - 11/2012
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 11/2012
4	Circular RNAIBA 10/2023 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 05/2023 - 01/2013
4	CytokinesIBA 01/2022 - 07/2007
3	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2022
3	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2015
3	Sirtuin 1IBA 01/2017 - 07/2015
3	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 07/2015
3	Glycoproteins (Glycoprotein)IBA 11/2014 - 01/2013
3	Matrix Metalloproteinases (MMPs)IBA 04/2012 - 01/2006
2	ResveratrolIBA 10/2023 - 07/2015
2	Proline (L-Proline)FDA Link 09/2022 - 09/2014
2	ZincIBA 09/2022 - 08/2022
2	Long Noncoding RNAIBA 01/2020 - 01/2014
2	Insulin-Like PeptidesIBA 12/2016 - 01/2014
2	Insulin-Like Growth Factor Binding Protein 3IBA 12/2016 - 01/2014
2	Decitabine FDA Link 11/2016 - 12/2014
2	MethyltransferasesIBA 11/2016 - 12/2014
2	ChemokinesIBA 01/2016 - 08/2011
2	ApolipoproteinsIBA 09/2014 - 11/2012
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2014 - 11/2012
2	Thrombospondin 1IBA 06/2014 - 01/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2014 - 08/2011
2	Inhibitor of Apoptosis ProteinsIBA 07/2013 - 01/2012
2	5' Untranslated Regions (5' UTR)IBA 07/2013 - 05/2012
2	SurvivinIBA 07/2013 - 01/2012
2	AndrogensIBA 03/2013 - 09/2011
2	Fas Ligand Protein (Fas Ligand)IBA 07/2011 - 09/2010
1	human ERBB2 proteinIBA 03/2024
1	Gemcitabine FDA Link 01/2024
1	Interleukin-2 (IL2)IBA 01/2024
1	Immunologic Factors (Immunomodulators)IBA 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024
1	N-acetoacetyl-N-deacetylcolchicineIBA 12/2023
1	Ghrelin ReceptorsIBA 11/2023
1	Natural Gas (Gas, Natural)IBA 11/2023
1	PolyphenolsIBA 10/2023
1	AllergensIBA 10/2023
1	Anti-Allergic Agents (Antiallergic Agents)IBA 10/2023
1	Sulfates (Sulfates, Inorganic)IBA 10/2023
1	SulfurIBA 10/2023
1	WastewaterIBA 08/2023
1	Urea (Carbamide)FDA LinkGeneric 08/2023
1	Indicators and Reagents (Reagents)IBA 05/2023
1	CarbonatesIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	3' Untranslated Regions (3' UTR)IBA 01/2023
1	venetoclaxIBA 01/2023

Therapy/Procedure

7	Therapeutics 03/2024 - 01/2015
6	Cystectomy 12/2023 - 12/2018
5	Immunotherapy 01/2024 - 01/2022
4	Nephrectomy 01/2023 - 01/2014
4	Radiotherapy 01/2020 - 12/2017
3	Drug Therapy (Chemotherapy) 01/2024 - 12/2017
3	Chemoradiotherapy 01/2023 - 01/2020
3	Neoadjuvant Therapy 12/2022 - 01/2022
2	Urinary Diversion (Ileal Conduit) 03/2022 - 01/2022
2	Warm Ischemia 01/2022 - 01/2020
2	Stents 06/2020 - 01/2014
2	Glycemic Control 07/2015 - 01/2015
1	Thrombectomy 01/2023